{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:32:36Z","timestamp":1793831556013,"version":"4.6.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005187","name":"University of Athens","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005187","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Myosteatosis in cirrhotic patients has been evaluated in limited studies with conflicting results and no systematic review or meta-analysis have been performed in this setting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We searched for all articles published until June 2023 to evaluate the prevalence of myosteatosis in cirrhosis and chronic liver disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Seventeen studies focused on cirrhosis and five studies in patients with chronic liver disease were included: the overall pooled prevalence of myosteatosis was 46% [95% Confidence Interval (CI) 36\u201357%] and 33% (95% CI 15\u201359%), respectively (<jats:italic>p<\/jats:italic>\u2009=\u20090.35). Among the studies with cirrhosis, the prevalence of myosteatosis was higher in those using the body mass index-based definition of myosteatosis (56%), than gender-based (36%) or other criteria (21%) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01); was higher in women than in men (61% vs 45%), in Child\u2013Pugh class C than A or B (57% vs 49% vs 50%), in non-alcoholic fatty liver disease (NAFLD)- than viral-associated cirrhosis (57% vs 43%), but these differences were not statistically significant (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). Cirrhotic patients with myosteatosis, compared to those without myosteatosis, had more frequently a previous history of hepatic encephalopathy (32% vs 15%, <jats:italic>p<\/jats:italic>\u2009=\u20090.04), less frequently a previous history of variceal bleeding (46% vs 65%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01), were more likely to suffer from diabetes mellitus (27% vs 18%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01), while they had higher mortality rates (40% vs 14%, <jats:italic>p<\/jats:italic>\u2009=\u20090.02).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Myosteatosis is highly prevalent in patients with cirrhosis, particularly in those with NAFLD-associated cirrhosis. Myosteatosis is associated with hepatic encephalopathy, while it seems to have a negative impact on the outcome.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12072-023-10632-8","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T07:02:02Z","timestamp":1707375722000},"page":"688-699","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"18","author":[{"given":"Aikaterini","family":"Kamiliou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Lekakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lampros","family":"Chrysavgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Cholongitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,8]]},"reference":[{"issue":"1","key":"10632_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/biomedicines10010182","volume":"10","author":"A Cespiati","year":"2022","unstructured":"Cespiati A, Meroni M, Lombardi R, Oberti G, Dongiovanni P, Fracanzani AL. Impact of sarcopenia and myosteatosis in non-cirrhotic stages of liver diseases: similarities and differences across aetiologies and possible therapeutic strategies. Biomedicines. 2022;10(1):182","journal-title":"Biomedicines"},{"issue":"7","key":"10632_CR2","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3390\/cells11071216","volume":"11","author":"M Ebadi","year":"2022","unstructured":"Ebadi M, Tsien C, Bhanji RA, Dunichand-Hoedl AR, Rider E, Motamedrad M, et al. Myosteatosis in cirrhosis: a review of diagnosis, pathophysiological mechanisms and potential interventions. Cells. 2022;11(7):1216","journal-title":"Cells"},{"issue":"3","key":"10632_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/apha.12224","volume":"210","author":"J Aubrey","year":"2014","unstructured":"Aubrey J, Esfandiari N, Baracos VE, Buteau FA, Frenette J, Putman CT, et al. Measurement of skeletal muscle radiation attenuation and basis of its biological variation. Acta Physiol (Oxf). 2014;210(3):489\u2013497","journal-title":"Acta Physiol (Oxf)"},{"issue":"6","key":"10632_CR4","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1002\/jcsm.13068","volume":"13","author":"J Lortie","year":"2022","unstructured":"Lortie J, Gage G, Rush B, Heymsfield SB, Szczykutowicz TP, Kuchnia AJ. The effect of computed tomography parameters on sarcopenia and myosteatosis assessment: a scoping review. J Cachexia Sarcopenia Muscle. 2022;13(6):2807\u20132819","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10632_CR5","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1002\/sim.4040","volume":"29","author":"T Stijnen","year":"2010","unstructured":"Stijnen T, Hamza TH, Ozdemir P. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med. 2010;29:3046\u20133067","journal-title":"Stat Med"},{"key":"10632_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","volume":"26","author":"CJ Clopper","year":"1934","unstructured":"Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrica. 1934;26:404\u2013413","journal-title":"Biometrica"},{"key":"10632_CR7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A","volume":"15","author":"RJ Hardy","year":"1996","unstructured":"Hardy RJ, Thompson SG. A likelihood approach to meta-analysis with random effects. Stat Med. 1996;15:619\u2013629","journal-title":"Stat Med"},{"key":"10632_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u2013560","journal-title":"BMJ"},{"key":"10632_CR9","doi-asserted-by":"publisher","first-page":"e010247","DOI":"10.1136\/bmjopen-2015-010247","volume":"6","author":"J Int Hout","year":"2016","unstructured":"Int Hout J, Ioannidis JP, Rovers MM, Goeman JJ. Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open. 2016;6:e010247","journal-title":"BMJ Open"},{"key":"10632_CR10","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2020. http:\/\/www.r-project.org\/index.html. Accessed 25 Jan 2021."},{"issue":"11","key":"10632_CR11","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.dld.2019.09.004","volume":"51","author":"B Lattanzi","year":"2019","unstructured":"Lattanzi B, Nardelli S, Pigliacelli A, Di Cola S, Farcomeni A, D\u2019Ambrosio D, et al. The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease. Dig Liver Dis. 2019;51(11):1508\u20131512","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10632_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/jcsm.12039","volume":"7","author":"AJ Montano-Loza","year":"2016","unstructured":"Montano-Loza AJ, Angulo P, Meza-Junco J, Prado CM, Sawyer MB, Beaumont C, et al. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis. J Cachexia Sarcopenia Muscle. 2016;7(2):126\u2013135","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"9","key":"10632_CR13","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.3390\/jcm12093332","volume":"12","author":"E Geladari","year":"2023","unstructured":"Geladari E, Alexopoulos T, Kontogianni MD, Vasilieva L, Mani I, Tenta R, et al. The presence of myosteatosis is associated with age, severity of liver disease and poor outcome and may represent a prodromal phase of sarcopenia in patients with liver cirrhosis. J Clin Med. 2023;12(9):3332","journal-title":"J Clin Med"},{"issue":"1S Suppl 1","key":"10632_CR14","doi-asserted-by":"publisher","first-page":"e916","DOI":"10.1097\/MEG.0000000000002303","volume":"33","author":"Y Sugiyama","year":"2021","unstructured":"Sugiyama Y, Ishizu Y, Ando Y, Yokoyama S, Yamamoto K, Ito T, et al. Obesity and myosteatosis: the two characteristics of dynapenia in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2021;33(1S Suppl 1):e916\u2013e921","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10632_CR15","doi-asserted-by":"publisher","first-page":"111777","DOI":"10.1016\/j.nut.2022.111777","volume":"103\u2013104","author":"Y Ishizu","year":"2022","unstructured":"Ishizu Y, Ishigami M, Honda T, Imai N, Ito T, Yamamoto K, et al. Factors associated with the progression of myosteatosis in patients with cirrhosis. Nutrition. 2022;103\u2013104:111777","journal-title":"Nutrition"},{"issue":"1","key":"10632_CR16","doi-asserted-by":"publisher","first-page":"13368","DOI":"10.1038\/s41598-021-92798-5","volume":"11","author":"FA Meister","year":"2021","unstructured":"Meister FA, Bednarsch J, Amygdalos I, Boecker J, Strnad P, Bruners P, et al. Various myosteatosis selection criteria and their value in the assessment of short- and long-term outcomes following liver transplantation. Sci Rep. 2021;11(1):13368","journal-title":"Sci Rep"},{"issue":"9","key":"10632_CR17","doi-asserted-by":"publisher","first-page":"921181","DOI":"10.3389\/fnut.2022.921181","volume":"15","author":"X Wang","year":"2022","unstructured":"Wang X, Sun M, Li Y, Guo G, Yang W, Mao L, et al. Association of myosteatosis with various body composition abnormalities and longer length of hospitalization in patients with decompensated cirrhosis. Front Nutr. 2022;15(9):921181","journal-title":"Front Nutr"},{"issue":"8","key":"10632_CR18","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.dld.2021.12.015","volume":"54","author":"S Nardelli","year":"2022","unstructured":"Nardelli S, Riggio O, Gioia S, Merli M, Spagnoli A, di Martino M, et al. Risk factors for hepatic encephalopathy and mortality in cirrhosis: The role of cognitive impairment, muscle alterations and shunts. Dig Liver Dis. 2022;54(8):1060\u20131065","journal-title":"Dig Liver Dis"},{"issue":"18","key":"10632_CR19","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.3748\/wjg.v29.i18.2875","volume":"29","author":"L Yin","year":"2023","unstructured":"Yin L, Chu SL, Lv WF, Zhou CZ, Liu KC, Zhu YJ, et al. Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt. World J Gastroenterol. 2023;29(18):2875\u20132887","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10632_CR20","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/hep.30692","volume":"70","author":"S Nardelli","year":"2019","unstructured":"Nardelli S, Lattanzi B, Merli M, Farcomeni A, Gioia S, Ridola L, et al. Muscle alterations are associated with minimal and overt hepatic encephalopathy in patients with liver cirrhosis. Hepatology. 2019;70(5):1704\u20131713","journal-title":"Hepatology"},{"key":"10632_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-023-10497-x","author":"X Zeng","year":"2023","unstructured":"Zeng X, Shi ZW, Yu JJ, Wang LF, Sun CY, Luo YY, et al. Skeletal muscle alterations indicate poor prognosis in cirrhotic patients: a multicenter cohort study in China. Hepatol Int. 2023. https:\/\/doi.org\/10.1007\/s12072-023-10497-x","journal-title":"Hepatol Int"},{"issue":"1","key":"10632_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3390\/jcm12010262","volume":"12","author":"C Masetti","year":"2022","unstructured":"Masetti C, Pugliese N, Lofino L, Colapietro F, Ceriani R, Lleo A, et al. Myosteatosis is not associated with complications or survival in HCC patients undergoing trans arterial embolization. J Clin Med. 2022;12(1):262","journal-title":"J Clin Med"},{"key":"10632_CR23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.clnesp.2021.01.022","volume":"42","author":"D Bot","year":"2021","unstructured":"Bot D, Droop A, Lucassen CJ, van Veen ME, van Vugt JLA, Shahbazi Feshtali S, et al. Both muscle quantity and quality are predictors of waiting list mortality in patients with end-stage liver disease. Clin Nutr ESPEN. 2021;42:272\u2013279","journal-title":"Clin Nutr ESPEN"},{"issue":"1","key":"10632_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.hpb.2019.06.006","volume":"22","author":"SD Shenvi","year":"2020","unstructured":"Shenvi SD, Taber DJ, Hardie AD, Botstein JO, McGillicuddy JW. Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients. HPB (Oxford). 2020;22(1):102\u2013108","journal-title":"HPB (Oxford)"},{"issue":"2","key":"10632_CR25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/ajt.15577","volume":"20","author":"Z Czigany","year":"2020","unstructured":"Czigany Z, Kramp W, Bednarsch J, van der Kroft G, Boecker J, Strnad P, et al. Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation. Am J Transplant. 2020;20(2):493\u2013503","journal-title":"Am J Transplant"},{"issue":"9","key":"10632_CR26","doi-asserted-by":"publisher","first-page":"948","DOI":"10.6002\/ect.2021.0083","volume":"19","author":"NEA Irwin","year":"2021","unstructured":"Irwin NEA, Fabian J, Hari KR, Lorentz L, Mahomed A, Botha JF. Myosteatosis, the more significant predictor of outcome: an analysis of the impact of myosteatosis, sarcopenia, and sarcopenic obesity on liver transplant outcomes in Johannesburg, South Africa. Exp Clin Transplant. 2021;19(9):948\u2013955","journal-title":"Exp Clin Transplant"},{"issue":"8","key":"10632_CR27","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1097\/TP.0000000000001232","volume":"100","author":"CW Wang","year":"2016","unstructured":"Wang CW, Feng S, Covinsky KE, Hayssen H, Zhou LQ, Yeh BM, et al. A comparison of muscle function, mass, and quality in liver transplant candidates: results from the functional assessment in liver transplantation study. Transplantation. 2016;100(8):1692\u20131698","journal-title":"Transplantation"},{"key":"10632_CR28","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/jpen.2508","volume":"47","author":"D Bot","year":"2023","unstructured":"Bot D, Klerks S, Leistra E, Tushuizen ME, van Hoek B. Association between skeletal muscle index prior to liver transplantation and 1-year mortality posttransplant. JPEN J Parenter Enteral Nutr. 2023;47:867\u2013877","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"4","key":"10632_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12072-018-9875-9","volume":"12","author":"RA Bhanji","year":"2018","unstructured":"Bhanji RA, Moctezuma-Velazquez C, Duarte-Rojo A, Ebadi M, Ghosh S, Rose C, et al. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis. Hepatol Int. 2018;12(4):377\u2013386","journal-title":"Hepatol Int"},{"issue":"8","key":"10632_CR30","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3390\/cells11081345","volume":"11","author":"M Ebadi","year":"2022","unstructured":"Ebadi M, Tsien C, Bhanji RA, Dunichand-Hoedl AR, Rider E, Motamedrad M, et al. Skeletal muscle pathological fat infiltration (myosteatosis) is associated with higher mortality in patients with cirrhosis. Cells. 2022;11(8):1345","journal-title":"Cells"},{"issue":"12","key":"10632_CR31","doi-asserted-by":"crossref","first-page":"204062232110269","DOI":"10.1177\/20406223211026996","volume":"27","author":"H Feng","year":"2021","unstructured":"Feng H, Wang X, Mao L, Yu Z, Cui B, Lin L, et al. Relationship between sarcopenia\/myosteatosis and frailty in hospitalized patients with cirrhosis: a sex-stratified analysis. Ther Adv Chronic Dis. 2021;27(12):20406223211026996","journal-title":"Ther Adv Chronic Dis"},{"issue":"12","key":"10632_CR32","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1111\/liv.15060","volume":"41","author":"S Gioia","year":"2021","unstructured":"Gioia S, Ridola L, Cristofaro L, Merli M, Faccioli J, Riggio O, et al. The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Liver Int. 2021;41(12):2965\u20132973","journal-title":"Liver Int"},{"issue":"2","key":"10632_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/jpen.1841","volume":"45","author":"L Hou","year":"2021","unstructured":"Hou L, Deng Y, Fan X, Zhao T, Cui B, Lin L, et al. A sex-stratified prognostic nomogram incorporating body compositions for long-term mortality in cirrhosis. JPEN J Parenter Enteral Nutr. 2021;45(2):403\u2013413","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10632_CR34","unstructured":"Wells GA, Shea B, O\u2019Connell D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analyses. 2004. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"issue":"4","key":"10632_CR35","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3350\/cmh.2023.0035","volume":"29","author":"HK Kim","year":"2023","unstructured":"Kim HK, Bae SJ, Lee MJ, Kim EH, Park H, Kim HS, et al. Association of visceral fat obesity, sarcopenia, and myosteatosis with non-alcoholic fatty liver disease without obesity. Clin Mol Hepatol. 2023;29(4):987\u20131001","journal-title":"Clin Mol Hepatol"},{"issue":"3","key":"10632_CR36","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/liv.14719","volume":"41","author":"YC Hsieh","year":"2021","unstructured":"Hsieh YC, Joo SK, Koo BK, Lin HC, Kim W. Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease. Liver Int. 2021;41(3):494\u2013504","journal-title":"Liver Int"},{"issue":"1","key":"10632_CR37","doi-asserted-by":"publisher","first-page":"100197","DOI":"10.1016\/j.jhepr.2020.100197","volume":"3","author":"J Linge","year":"2020","unstructured":"Linge J, Ekstedt M, Dahlqvist LO. Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD. JHEP Rep. 2020;3(1):100197","journal-title":"JHEP Rep"},{"key":"10632_CR38","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1111\/jgh.14133","volume":"33","author":"Y Tachi","year":"2018","unstructured":"Tachi Y, Kozuka A, Hirai T, Ishizu Y, Honda T, Kuzuya T, et al. Impact of myosteatosis on skeletal muscle volume loss in patients with chronic liver disease. J Gastroenterol Hepatol. 2018;33:1659\u20131666","journal-title":"J Gastroenterol Hepatol"},{"issue":"11","key":"10632_CR39","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.dld.2023.08.037","volume":"55","author":"M Praktiknjo","year":"2023","unstructured":"Praktiknjo M, Zhou T, Kr\u00fcsken M, Jacob T, Sprinkart AM, Nowak S, et al. Myosteatosis independently predicts transplant-free survival in patients with primary sclerosing cholangitis. Dig Liver Dis. 2023;55(11):1543\u20131547","journal-title":"Dig Liver Dis"},{"key":"10632_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.nut.2018.03.011","volume":"54","author":"Y Tachi","year":"2018","unstructured":"Tachi Y, Kozuka A, Hirai T, Kojima Y, Ishizu Y, Honda T, et al. Skeletal muscle fat deposition is associated with hepatocellular carcinoma development in patients with chronic liver disease. Nutrition. 2018;54:83\u201388","journal-title":"Nutrition"},{"issue":"3","key":"10632_CR41","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/biom.12817","volume":"74","author":"L Lin","year":"2018","unstructured":"Lin L, Chu H. Quantifying publication bias in meta-analysis. Biometrics. 2018;74(3):785\u2013794. https:\/\/doi.org\/10.1111\/biom.12817","journal-title":"Biometrics"},{"key":"10632_CR42","doi-asserted-by":"publisher","first-page":"111866","DOI":"10.1016\/j.nut.2022.111866","volume":"105","author":"T Fang","year":"2023","unstructured":"Fang T, Gong Y, Wang Y. Prognostic values of myosteatosis for overall survival in patients with gastric cancers: a meta-analysis with trial sequential analysis. Nutrition. 2023;105:111866","journal-title":"Nutrition"},{"issue":"6","key":"10632_CR43","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1016\/j.clnu.2021.04.017","volume":"40","author":"HK Kim","year":"2021","unstructured":"Kim HK, Kim KW, Kim EH, Lee MJ, Bae SJ, Ko Y, et al. Age-related changes in muscle quality and development of diagnostic cutoff points for myosteatosis in lumbar skeletal muscles measured by CT scan. Clin Nutr. 2021;40(6):4022\u20134028","journal-title":"Clin Nutr"},{"key":"10632_CR44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ejrad.2018.06.023","volume":"105","author":"LS Kiefer","year":"2018","unstructured":"Kiefer LS, Fabian J, Rospleszcz S, Lorbeer R, Machann J, Storz C, et al. Assessment of the degree of abdominal myosteatosis by magnetic resonance imaging in subjects with diabetes, prediabetes and healthy controls from the general population. Eur J Radiol. 2018;105:261\u2013268","journal-title":"Eur J Radiol"},{"issue":"8","key":"10632_CR45","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.clnu.2023.06.032","volume":"42","author":"A Sabatino","year":"2023","unstructured":"Sabatino A, Avesani CM, Regolisti G, Adinolfi M, Benigno G, Delsante M, et al. Sarcopenic obesity and its relation with muscle quality and mortality in patients on chronic hemodialysis. Clin Nutr. 2023;42(8):1359\u20131368","journal-title":"Clin Nutr"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10632-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-023-10632-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-023-10632-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T19:12:00Z","timestamp":1712949120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-023-10632-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10632"],"URL":"https:\/\/doi.org\/10.1007\/s12072-023-10632-8","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,8]]},"assertion":[{"value":"18 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Aikaterini Kamiliou, Vasileios Lekakis, Lampros Chrysavgis, Evangelos Cholongitas declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}